Division of Rheumatology, Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.
Sci Rep. 2021 Dec 31;11(1):24512. doi: 10.1038/s41598-021-04291-8.
We aimed to search for common features in the autoreactive T cell receptor (TCR) repertoire in patients with rheumatoid arthritis (RA), focusing on the newly identified candidate antigen citrullinated Tenascin C (cit-TNC). Mononuclear cells from peripheral blood or synovial fluid of eight RA-patients positive for the RA-associated HLA-DRB1*04:01 allele were in-vitro cultured with recently identified citrullinated peptides from Tenascin C. Antigen-specific T cells were isolated using peptide-HLA tetramer staining and subsequently single-cell sequenced for paired alpha/beta TCR analyses by bioinformatic tools. TCRs were re-expressed for further studies of antigen-specificity and T cell responses. Autoreactive T cell lines could be grown out from both peripheral blood and synovial fluid. We demonstrate the feasibility of retrieving true autoreactive TCR sequences by validating antigen-specificity in T cell lines with re-expressed TCRs. One of the Tenascin C peptides, cit-TNC22, gave the most robust T cell responses including biased TCR gene usage patterns. The shared TCR-beta chain signature among the cit-TNC22-specific TCRs was evident in blood and synovial fluid of different patients. The identification of common elements in the autoreactive TCR repertoire gives promise to the possibility of both immune monitoring of the autoimmune components in RA and of future antigen- or TCR-targeted specific intervention in subsets of patients.
我们旨在寻找类风湿关节炎(RA)患者自身反应性 T 细胞受体(TCR)谱中的共同特征,重点关注新确定的候选抗原瓜氨酸化 Tenascin C(cit-TNC)。用最近从 Tenascin C 中鉴定出的瓜氨酸化肽体外培养 8 例 HLA-DRB1*04:01 等位基因阳性的 RA 患者的外周血或滑膜液中的单核细胞。使用肽-HLA 四聚体染色分离抗原特异性 T 细胞,然后通过生物信息学工具对单个细胞进行配对的α/β TCR 分析进行单细胞测序。TCR 被重新表达,用于进一步研究抗原特异性和 T 细胞反应。可以从外周血和滑膜液中培养出自反应性 T 细胞系。我们通过用重新表达的 TCR 验证 T 细胞系中的抗原特异性来证明检索真正自身反应性 TCR 序列的可行性。Tenascin C 肽中的一种,cit-TNC22,引起了最强烈的 T 细胞反应,包括偏倚的 TCR 基因使用模式。在不同患者的血液和滑膜液中,cit-TNC22 特异性 TCR 之间存在共享的 TCR-β链特征。在自身反应性 TCR 谱中鉴定出共同元素,为 RA 中自身免疫成分的免疫监测以及未来针对患者亚群的抗原或 TCR 靶向特异性干预提供了可能。